30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Opiant Pharmaceuticals Inc (OPNT)

Track

Stock chart
Ticker: OPNT Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Gorman Brian
1 sale — total 8,995 USD
Sale 27 Jan 2023
Value US$1,832,177.29 | Price 216.57 | Shares 612
Sale 27 Jan 2023
Value US$3,010,419.64 | Price 259.47 | Shares 29,399
Sale 27 Jan 2023
Value US$12,358.60 | Price 20.26 | Shares 610
Sale 27 Jan 2023
Value US$27,513.08 | Price 20.26 | Shares 1,358
Sale 27 Jan 2023
Value US$9,724.80 | Price 20.26 | Shares 480
Sale 9 Jan 2023
Value US$7,453.80 | Price 20.20 | Shares 369
Sale 9 Jan 2023
Value US$9,473.80 | Price 20.20 | Shares 469
Sale 9 Jan 2023
Value US$8,383.00 | Price 20.20 | Shares 415
Sale 9 Jan 2023
Value US$23,896.60 | Price 20.20 | Shares 1,183
Sale 5 Jan 2023
Value US$28,704.20 | Price 20.20 | Shares 1,421
Sale 5 Jan 2023
Value US$26,522.60 | Price 20.20 | Shares 1,313
Sale 5 Jan 2023
Value US$32,320.00 | Price 20.20 | Shares 1,600
Sale 5 Jan 2023
Value US$101,585.80 | Price 20.20 | Shares 5,029
Sale 5 Jan 2023
Value US$36,481.20 | Price 20.20 | Shares 1,806
Sale 20 Jul 2022
Value US$11,512.08 | Price 10.62 | Shares 1,084
Sale 14 Jul 2022
Value US$24,953.06 | Price 11.11 | Shares 2,246
Sale 14 Jul 2022
Value US$8,646.90 | Price 11.10 | Shares 779
Sale 14 Jul 2022
Value US$7,711.56 | Price 11.16 | Shares 691
Sale 14 Jul 2022
Value US$7,429.95 | Price 11.85 | Shares 627
Sale 15 Jun 2022
Value US$9,540.00 | Price 10.60 | Shares 900
Sale 14 Jun 2022
Value US$78,752.50 | Price 10.90 | Shares 7,225
Sale 13 Jun 2022
Value US$60,895.19 | Price 11.09 | Shares 5,491
Buy 13 Jun 2022
Value US$44,148.63 | Price 10.94 | Shares 4,037
Buy 10 Jun 2022
Value US$19,117.85 | Price 11.50 | Shares 1,663
Sale 9 Jun 2022
Value US$96,726.00 | Price 12.25 | Shares 7,896
Sale 7 Jun 2022
Value US$10,288.00 | Price 12.86 | Shares 800
Sale 6 Jun 2022
Value US$99,482.72 | Price 12.94 | Shares 7,688
Sale 3 Jun 2022
Value US$139,487.76 | Price 13.59 | Shares 10,264
Sale 2 Jun 2022
Value US$15,520.96 | Price 13.52 | Shares 1,148
Sale 2 Jun 2022
Value US$135,135.68 | Price 13.88 | Shares 9,736
Buy 16 May 2022
Value US$367,611.00 | Price 13.54 | Shares 27,150
Buy 16 May 2022
Value US$33,220.00 | Price 13.29 | Shares 2,500
Buy 13 May 2022
Value US$38,697.61 | Price 10.49 | Shares 3,689
Buy 13 May 2022
Value US$32,778.00 | Price 10.93 | Shares 3,000
Sale 27 Jan 2022
Value US$52,169.25 | Price 26.15 | Shares 1,995
Sale 27 Jan 2022
Value US$39,756.42 | Price 26.19 | Shares 1,518
Sale 10 Jan 2022
Value US$32,258.42 | Price 30.49 | Shares 1,058
Sale 10 Jan 2022
Value US$13,219.20 | Price 30.60 | Shares 432
Sale 10 Jan 2022
Value US$11,738.65 | Price 30.49 | Shares 385
Buy 14 Sep 2021
Value US$227.64 | Price 18.97 | Shares 12
Buy 14 Sep 2021
Value US$24,752.00 | Price 19.04 | Shares 1,300
Buy 10 Sep 2021
Value US$174,109.86 | Price 18.18 | Shares 9,577
Sale 19 Aug 2021
Value US$6,500.00 | Price 16.25 | Shares 400
Sale 19 Aug 2021
Value US$9,720.00 | Price 16.20 | Shares 600
Buy 16 Aug 2021
Value US$9,228.00 | Price 15.38 | Shares 600
Sale 17 Mar 2021
Value US$79,227.99 | Price 11.07 | Shares 7,157
Sale 17 Mar 2021
Value US$73,128.42 | Price 11.07 | Shares 6,606
Sale 16 Mar 2021
Value US$22,413.50 | Price 11.50 | Shares 1,949
Sale 16 Mar 2021
Value US$22,413.50 | Price 11.50 | Shares 1,949
Sale 15 Mar 2021
Value US$45,396.00 | Price 11.64 | Shares 3,900
Sale 15 Mar 2021
Value US$65,128.00 | Price 11.63 | Shares 5,600
Buy 4 Sep 2020
Value US$4,025.00 | Price 8.05 | Shares 500
Buy 3 Sep 2020
Value US$21,000.00 | Price 8.40 | Shares 2,500
Buy 11 Jun 2020
Value US$8,740.00 | Price 8.74 | Shares 1,000
Buy 10 Jun 2020
Value US$24,924.90 | Price 9.13 | Shares 2,730
Buy 26 May 2020
Value US$11,000.00 | Price 11.00 | Shares 1,000
Planned sale 8 Jan 2020
Value US$38,253.32 | Price 13.46 | Shares 2,842
Planned sale 7 Jan 2020
Value US$40,654.48 | Price 13.36 | Shares 3,043
Planned sale 7 Jan 2020
Value US$39,440.00 | Price 13.60 | Shares 2,900
Planned sale 6 Jan 2020
Value US$7,107.00 | Price 13.80 | Shares 515
Planned sale 2 Jan 2020
Value US$9,856.00 | Price 14.08 | Shares 700
Buy 12 Dec 2019
Value US$72,700.00 | Price 14.54 | Shares 5,000
Planned sale 6 Dec 2019
Value US$10,672.00 | Price 13.34 | Shares 800
Planned sale 5 Dec 2019
Value US$28,263.18 | Price 13.74 | Shares 2,057
Planned sale 3 Dec 2019
Value US$63,771.54 | Price 13.93 | Shares 4,578
Planned sale 2 Dec 2019
Value US$36,346.05 | Price 14.17 | Shares 2,565
Buy 26 Nov 2019
Value US$1,322.00 | Price 13.22 | Shares 100
Buy 22 Nov 2019
Value US$24,115.35 | Price 13.51 | Shares 1,785
Buy 15 Nov 2019
Value US$1,500.00 | Price 15.00 | Shares 100
Buy 15 Nov 2019
Value US$14,910.00 | Price 14.91 | Shares 1,000
Planned sale 5 Nov 2019
Value US$37,225.00 | Price 14.89 | Shares 2,500
Planned sale 4 Nov 2019
Value US$4,568.72 | Price 15.28 | Shares 299
Planned sale 1 Nov 2019
Value US$108,735.10 | Price 15.10 | Shares 7,201
Planned sale 3 Oct 2019
Value US$22,960.43 | Price 14.27 | Shares 1,609
Planned sale 2 Oct 2019
Value US$16,056.14 | Price 14.57 | Shares 1,102
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-01-31 2023-01-27 S Sale
3.3
Gorman Brian
612 +8.0%
216.57
US$1,832,177 		612 +8.0% 216.57 US$1,832,177
2023-01-31 2023-01-27 S Sale
2.7
O'Toole David D

Chief Financial Officer

Officer
29,399 +8.4%
259.47
US$3,010,420 		29,399 +8.4% 259.47 US$3,010,420
2023-01-31 2023-01-27 S Sale
Ellison Mark Jason Heath

Chief Development Officer

Officer
75,503 +49.1%
108.88
US$1,561,803 		75,503 +49.1% 108.88 US$1,561,803
2023-01-31 2023-01-27 S Sale
CRYSTAL ROGER

Chief Executive Officer

Executive Director Large shareholder
1,358 -1.8%
20.26
US$27,513 		1,358 -1.8% 20.26 US$27,513
2023-01-31 2023-01-27 S Sale
Skolnick Phil

Chief Scientific Officer

Officer
480 -2.2%
20.26
US$9,725 		480 -2.2% 20.26 US$9,725
2023-01-09 2023-01-09 S Sale
Skolnick Phil

Chief Scientific Officer

Officer
369 -1.6%
20.20
US$7,454 		369 -1.6% 20.20 US$7,454
2023-01-09 2023-01-09 S Sale
Ellison Mark Jason Heath

Chief Development Officer

Officer
469 -2.4%
20.20
US$9,474 		469 -2.4% 20.20 US$9,474
2023-01-09 2023-01-09 S Sale
2.7
O'Toole David D

Chief Financial Officer

Officer
415 -1.2%
20.20
US$8,383 		415 -1.2% 20.20 US$8,383
2023-01-09 2023-01-09 S Sale
CRYSTAL ROGER

Chief Executive Officer

Executive Director Large shareholder
1,183 -1.5%
20.20
US$23,897 		1,183 -1.5% 20.20 US$23,897
2023-01-05 2023-01-05 S Sale
Skolnick Phil

Chief Scientific Officer

Officer
1,421 -6.0%
20.20
US$28,704 		1,421 -6.0% 20.20 US$28,704
2023-01-05 2023-01-05 S Sale
3.3
Gorman Brian
1,313 -3.9%
20.20
US$26,523 		1,313 -3.9% 20.20 US$26,523
2023-01-05 2023-01-05 S Sale
2.7
O'Toole David D

Chief Financial Officer

Officer
1,600 -4.3%
20.20
US$32,320 		1,600 -4.3% 20.20 US$32,320
2023-01-05 2023-01-05 S Sale
CRYSTAL ROGER

Chief Executive Officer

Executive Director Large shareholder
5,029 -6.1%
20.20
US$101,586 		5,029 -6.1% 20.20 US$101,586
2023-01-05 2023-01-05 S Sale
Ellison Mark Jason Heath

Chief Development Officer

Officer
1,806 -8.3%
20.20
US$36,481 		1,806 -8.3% 20.20 US$36,481
2022-07-21 2022-07-20 S Sale
Ruth Matthew R.

Chief Commercial Officer

Officer
1,084 -3.5%
10.62
US$11,512 		1,084 -3.5% 10.62 US$11,512
2022-07-15 2022-07-14 S Sale
CRYSTAL ROGER

Chief Executive Officer

Executive Director Large shareholder
2,246 -2.6%
11.11
US$24,953 		2,246 -2.6% 11.11 US$24,953
2022-07-15 2022-07-14 S Sale
2.7
O'Toole David D

Chief Financial Officer

Officer
779 -2.1%
11.10
US$8,647 		779 -2.1% 11.10 US$8,647
2022-07-15 2022-07-14 S Sale
3.3
Gorman Brian
691 -2.0%
11.16
US$7,712 		691 -2.0% 11.16 US$7,712
2022-07-15 2022-07-14 S Sale
Skolnick Phil

Chief Scientific Officer

Officer
627 -2.6%
11.85
US$7,430 		627 -2.6% 11.85 US$7,430
2022-06-15 2022-06-15 S Sale
2.4
Sinclair Michael
Non-Executive Director Large shareholder
900 -4.5%
10.60
US$9,540 		900 -4.5% 10.60 US$9,540
2022-06-15 2022-06-14 S Sale
2.4
Sinclair Michael
Non-Executive Director Large shareholder
7,225 -26.4%
10.90
US$78,752 		7,225 -26.4% 10.90 US$78,752
2022-06-15 2022-06-13 S Sale
2.4
Sinclair Michael
Non-Executive Director Large shareholder
5,491 -16.7%
11.09
US$60,895 		5,491 -16.7% 11.09 US$60,895
2022-06-13 2022-06-13 B Purchase
3.7
Collard Craig A
Non-Executive Director
4,037 +8.1%
10.94
US$44,149 		4,037 +8.1% 10.94 US$44,149
2022-06-13 2022-06-10 B Purchase
3.7
Collard Craig A
Non-Executive Director
1,663 +3.5%
11.50
US$19,118 		1,663 +3.5% 11.50 US$19,118
2022-06-13 2022-06-09 S Sale
2.4
Sinclair Michael
Non-Executive Director Large shareholder
7,896 -19.4%
12.25
US$96,726 		7,896 -19.4% 12.25 US$96,726
2022-06-08 2022-06-07 S Sale
2.4
Sinclair Michael
Non-Executive Director Large shareholder
800 -1.9%
12.86
US$10,288 		800 -1.9% 12.86 US$10,288
2022-06-08 2022-06-06 S Sale
2.4
Sinclair Michael
Non-Executive Director Large shareholder
7,688 -15.6%
12.94
US$99,483 		7,688 -15.6% 12.94 US$99,483
2022-06-06 2022-06-03 S Sale
2.4
Sinclair Michael
Non-Executive Director Large shareholder
10,264 -17.3%
13.59
US$139,488 		10,264 -17.3% 13.59 US$139,488
2022-06-06 2022-06-02 S Sale
3.3
Gorman Brian
1,148 -3.4%
13.52
US$15,521 		1,148 -3.4% 13.52 US$15,521
2022-06-06 2022-06-02 S Sale
2.4
Sinclair Michael
Non-Executive Director Large shareholder
9,736 -14.1%
13.88
US$135,136 		9,736 -14.1% 13.88 US$135,136
2022-05-17 2022-05-16 B Purchase
3.7
Collard Craig A
Non-Executive Director
27,150 +129.5%
13.54
US$367,611 		27,150 +129.5% 13.54 US$367,611
2022-05-17 2022-05-16 B Purchase
2.2
Silver Gabrielle Alison
Non-Executive Director
2,500 +13.3%
13.29
US$33,220 		2,500 +13.3% 13.29 US$33,220
2022-05-16 2022-05-13 B Purchase
3.7
Collard Craig A
Non-Executive Director
3,689 +21.3%
10.49
US$38,698 		3,689 +21.3% 10.49 US$38,698
2022-05-16 2022-05-13 B Purchase
2.1
MacDougall Ann L.
Non-Executive Director
3,000 +12.9%
10.93
US$32,778 		3,000 +12.9% 10.93 US$32,778
2022-01-27 2022-01-27 S Sale
CRYSTAL ROGER

Chief Executive Officer

Executive Director Large shareholder
1,995 -2.5%
26.15
US$52,169 		1,995 -2.5% 26.15 US$52,169
2022-01-27 2022-01-27 S Sale
Skolnick Phil

Chief Scientific Officer

Officer
1,518 -6.3%
26.19
US$39,756 		1,518 -6.3% 26.19 US$39,756
2022-01-12 2022-01-10 S Sale
CRYSTAL ROGER

Chief Executive Officer

Executive Director Large shareholder
1,058 -1.3%
30.49
US$32,258 		1,058 -1.3% 30.49 US$32,258
2022-01-12 2022-01-10 S Sale
2.7
O'Toole David D

Chief Financial Officer

Officer
432 -1.2%
30.60
US$13,219 		432 -1.2% 30.60 US$13,219
2022-01-12 2022-01-10 S Sale
Skolnick Phil

Chief Scientific Officer

Officer
385 -1.6%
30.49
US$11,739 		385 -1.6% 30.49 US$11,739
2021-09-14 2021-09-14 B Purchase
3.3
Gorman Brian
12 +0.1%
18.97
US$228 		12 +0.1% 18.97 US$228
2021-09-14 2021-09-14 B Purchase
3.3
Gorman Brian
1,300 +6.4%
19.04
US$24,752 		1,300 +6.4% 19.04 US$24,752
2021-09-13 2021-09-10 B Purchase
3.7
Collard Craig A
Non-Executive Director
9,577 +239.4%
18.18
US$174,110 		9,577 +239.4% 18.18 US$174,110
2021-08-20 2021-08-19 S Sale
2.5
Thomas Thomas T.
Non-Executive Director
400 -6.2%
16.25
US$6,500 		400 -6.2% 16.25 US$6,500
2021-08-20 2021-08-19 S Sale
2.5
Thomas Thomas T.
Non-Executive Director
600 -8.6%
16.20
US$9,720 		600 -8.6% 16.20 US$9,720
2021-08-16 2021-08-16 B Purchase
2.7
O'Toole David D

Chief Financial Officer

Officer
600 +2.6%
15.38
US$9,228 		600 +2.6% 15.38 US$9,228
2021-03-17 2021-03-17 S Sale
2.2
Silver Gabrielle Alison
Non-Executive Director
7,157 -30.3%
11.07
US$79,228 		7,157 -30.3% 11.07 US$79,228
2021-03-17 2021-03-17 S Sale
2.1
MacDougall Ann L.
Non-Executive Director
6,606 -24.1%
11.07
US$73,128 		6,606 -24.1% 11.07 US$73,128
2021-03-17 2021-03-16 S Sale
2.2
Silver Gabrielle Alison
Non-Executive Director
1,949 -11.0%
11.50
US$22,414 		1,949 -11.0% 11.50 US$22,414
2021-03-17 2021-03-16 S Sale
2.1
MacDougall Ann L.
Non-Executive Director
1,949 -8.8%
11.50
US$22,414 		1,949 -8.8% 11.50 US$22,414
2021-03-17 2021-03-15 S Sale
2.2
Silver Gabrielle Alison
Non-Executive Director
3,900 -20.1%
11.64
US$45,396 		3,900 -20.1% 11.64 US$45,396
2021-03-17 2021-03-15 S Sale
2.1
MacDougall Ann L.
Non-Executive Director
5,600 -22.0%
11.63
US$65,128 		5,600 -22.0% 11.63 US$65,128
2020-09-08 2020-09-04 B Purchase
2.5
Thomas Thomas T.
Non-Executive Director
500 +11.1%
8.05
US$4,025 		500 +11.1% 8.05 US$4,025
2020-09-08 2020-09-03 B Purchase
2.5
Thomas Thomas T.
Non-Executive Director
2,500 +125.0%
8.40
US$21,000 		2,500 +125.0% 8.40 US$21,000
2020-06-11 2020-06-11 B Purchase
2.7
O'Toole David D

Chief Financial Officer

Officer
1,000 +7.0%
8.74
US$8,740 		1,000 +7.0% 8.74 US$8,740
2020-06-12 2020-06-10 B Purchase
2.2
Silver Gabrielle Alison
Non-Executive Director
2,730 +152.9%
9.13
US$24,925 		2,730 +152.9% 9.13 US$24,925
2020-05-26 2020-05-26 B Purchase
2.7
O'Toole David D

Chief Financial Officer

Officer
1,000 +7.5%
11.00
US$11,000 		1,000 +7.5% 11.00 US$11,000
2020-01-09 2020-01-08 PlS Planned sale
Skolnick Phil

Chief Scientific Officer
2,842 -28.3%
13.46
US$38,253 		2,842 -28.3% 13.46 US$38,253
2020-01-09 2020-01-07 PlS Planned sale
Skolnick Phil

Chief Scientific Officer
3,043 -42.3%
13.36
US$40,654 		3,043 -42.3% 13.36 US$40,654
2020-01-09 2020-01-07 PlS Planned sale
Skolnick Phil

Chief Scientific Officer
2,900 -33.0%
13.60
US$39,440 		2,900 -33.0% 13.60 US$39,440
2020-01-06 2020-01-06 PlS Planned sale
Skolnick Phil

Chief Scientific Officer
515 -5.5%
13.80
US$7,107 		515 -5.5% 13.80 US$7,107
2020-01-06 2020-01-02 PlS Planned sale
Skolnick Phil

Chief Scientific Officer
700 -7.0%
14.08
US$9,856 		700 -7.0% 14.08 US$9,856
2019-12-12 2019-12-12 B Purchase MacDougall Ann L. Non-Executive Director
5,000 +100.0%
14.54
US$72,700 		5,000 +100.0% 14.54 US$72,700
2019-12-06 2019-12-06 PlS Planned sale Skolnick Phil

Chief Scientific Officer

Officer
800 -100.0%
13.34
US$10,672 		800 -100.0% 13.34 US$10,672
2019-12-06 2019-12-05 PlS Planned sale Skolnick Phil

Chief Scientific Officer

Officer
2,057 -72.0%
13.74
US$28,263 		2,057 -72.0% 13.74 US$28,263
2019-12-04 2019-12-03 PlS Planned sale Skolnick Phil

Chief Scientific Officer

Officer
4,578 -61.6%
13.93
US$63,772 		4,578 -61.6% 13.93 US$63,772
2019-12-04 2019-12-02 PlS Planned sale Skolnick Phil

Chief Scientific Officer

Officer
2,565 -25.7%
14.17
US$36,346 		2,565 -25.7% 14.17 US$36,346
2019-11-26 2019-11-26 B Purchase O'Toole David D

Chief Financial Officer

Officer
100 +1.1%
13.22
US$1,322 		100 +1.1% 13.22 US$1,322
2019-11-25 2019-11-22 B Purchase Silver Gabrielle Alison Non-Executive Director
1,785 +inf%
13.51
US$24,115 		1,785 +inf% 13.51 US$24,115
2019-11-15 2019-11-15 B Purchase
2.7
O'Toole David D

Chief Financial Officer
100 +1.1%
15.00
US$1,500 		100 +1.1% 15.00 US$1,500
2019-11-15 2019-11-15 B Purchase
2.7
O'Toole David D

Chief Financial Officer
1,000 +12.5%
14.91
US$14,910 		1,000 +12.5% 14.91 US$14,910
2019-11-05 2019-11-05 PlS Planned sale
Skolnick Phil

Chief Scientific Officer
2,500 -100.0%
14.89
US$37,225 		2,500 -100.0% 14.89 US$37,225
2019-11-05 2019-11-04 PlS Planned sale
Skolnick Phil

Chief Scientific Officer
299 -10.7%
15.28
US$4,569 		299 -10.7% 15.28 US$4,569
2019-11-05 2019-11-01 PlS Planned sale
Skolnick Phil

Chief Scientific Officer
7,201 -72.0%
15.10
US$108,735 		7,201 -72.0% 15.10 US$108,735
2019-10-03 2019-10-03 PlS Planned sale
Skolnick Phil

Chief Scientific Officer
1,609 -100.0%
14.27
US$22,960 		1,609 -100.0% 14.27 US$22,960
2019-10-03 2019-10-02 PlS Planned sale
Skolnick Phil

Chief Scientific Officer
1,102 -40.6%
14.57
US$16,056 		1,102 -40.6% 14.57 US$16,056
Explore more

More insider trading research around Opiant Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America